Bozkaya, Y. Et Al. 2018. Is serum survivin expression a predictive biomarker in locally advanced gastric cancer patients treated with neoadjuvant chemotherapy?. CANCER BIOMARKERS , vol.22, no.1 , 143-149.

Bozkaya, Y., Ozdemir, N. Y., Sezer, S., Kostek, O., Demirci, N. S., Yazici, O., ... Erdem, G. U.(2018). Is serum survivin expression a predictive biomarker in locally advanced gastric cancer patients treated with neoadjuvant chemotherapy?. CANCER BIOMARKERS , vol.22, no.1, 143-149.

Bozkaya, Yakup Et Al. "Is serum survivin expression a predictive biomarker in locally advanced gastric cancer patients treated with neoadjuvant chemotherapy?," CANCER BIOMARKERS , vol.22, no.1, 143-149, 2018

Bozkaya, Yakup Et Al. "Is serum survivin expression a predictive biomarker in locally advanced gastric cancer patients treated with neoadjuvant chemotherapy?." CANCER BIOMARKERS , vol.22, no.1, pp.143-149, 2018

Bozkaya, Y. Et Al. (2018) . "Is serum survivin expression a predictive biomarker in locally advanced gastric cancer patients treated with neoadjuvant chemotherapy?." CANCER BIOMARKERS , vol.22, no.1, pp.143-149.

@article{article, author={Yakup Bozkaya Et Al. }, title={Is serum survivin expression a predictive biomarker in locally advanced gastric cancer patients treated with neoadjuvant chemotherapy?}, journal={CANCER BIOMARKERS}, year=2018, pages={143-149} }